Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
書誌事項
- 公開日
- 2009-07-23
- 権利情報
-
- https://www.springer.com/tdm
- https://www.springer.com/tdm
- DOI
-
- 10.1038/leu.2009.147
- 公開者
- Springer Science and Business Media LLC
この論文をさがす
収録刊行物
-
- Leukemia
-
Leukemia 23 (11), 2147-2152, 2009-07-23
Springer Science and Business Media LLC
